Filing Details

Accession Number:
0001019231-24-000025
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-06-12 18:18:42
Reporting Period:
2024-06-10
Accepted Time:
2024-06-12 18:18:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1420565 Aileron Therapeutics Inc. ALRN () TX
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1019231 University Of Texas/Texas Am Investment Management Co 210 W. 7Th Street, Suite 1700
Austin TX 78701
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-06-10 9,577 $3.30 1,768,250 No 4 S Direct
Common Stock Disposition 2024-06-11 5,250 $3.25 1,763,000 No 4 S Direct
Common Stock Disposition 2024-06-11 502 $3.35 1,762,498 No 4 S Direct
Common Stock Disposition 2024-06-12 9,341 $3.25 1,753,157 No 4 S Direct
Common Stock Disposition 2024-06-12 1 $3.28 1,753,156 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. Pursuant to an Investment Management Services Agreement with the Board of Regents of the University of Texas System (the "Regents"), The University of Texas/Texas A&M Investment Management Company, an institutional investment advisor, holds the shares reported herein on behalf of the Regents and is authorized to exercise investment discretion and voting power with respect to such shares on behalf of the Regents.